CELLF BIO Achieves Milestone With First In Human Implantation of BioSphincter
| IIMOX Fund | USD 6.04 0.01 0.17% |
Slightly above 56% of Voya Midcap's investor base is looking to short. The analysis of overall sentiment of trading Voya Midcap Opportunities mutual fund suggests that many investors are alarmed at this time. Voya Midcap's investing sentiment can be driven by a variety of factors including economic data, Voya Midcap's earnings reports, geopolitical events, and overall market trends.
Voya |
RICHMOND, Va., June 06, 2023 CELLF BIO achieved a major milestone with the worlds first human implantation of BioSphincter, an autologous bioengineered sphincter made of smooth muscle and differentiated neural stem cells. The Phase 1 clinical trial is being conducted to treat patients with fecal incontinence , a condition that affects millions of people worldwide. The implantation surgery was performed by Dr. Jaime Bohl, chief of colon and rectal surgery at the Virginia
Read at finance.yahoo.com
 |
Voya Midcap Fundamental Analysis
We analyze Voya Midcap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Voya Midcap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Voya Midcap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Voya Midcap is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Voya Midcap Opportunities Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Voya Midcap mutual fund to make a market-neutral strategy. Peer analysis of Voya Midcap could also be used in its relative valuation, which is a method of valuing Voya Midcap by comparing valuation metrics with similar companies.
Peers
Voya Midcap Related Equities
| IMCVX | Voya Multi | 1.07 | ||||
| ILABX | Voya Bond | 0.22 | ||||
| ILBPX | Voya Limited | 0.11 | ||||
| IMBAX | Voya Limited | 0.11 | ||||
| IMCDX | Voya Emerging | 0.00 | ||||
| ILMBX | Voya Limited | 0.10 | ||||
| IMORX | Voya Midcap | 0.17 | ||||
| IMOPX | Voya Midcap | 0.26 | ||||
| ILBAX | Voya Bond | 0.33 | ||||
| ILUAX | Voya Bond | 0.34 |
Other Information on Investing in Voya Mutual Fund
Voya Midcap financial ratios help investors to determine whether Voya Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Voya with respect to the benefits of owning Voya Midcap security.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |